Skip to content

EBIT at other companies

NeoGenomics logo
NeoGenomicsNEO
-$18.24M+34.4%
Veracyte logo
VeracyteVCYT
$22.65M+680%
Quest Diagnostics logo
Quest DiagnosticsDGX
Illumina logo
IlluminaILMN
Guardant Health logo
Guardant HealthGH
Natera, Inc. logo
Natera, Inc.NTRA

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.19B+110%
Enterprise value$1.16B+115%
P/S18.4×+11.8×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Calculated from Personalis, Inc.’s reported figures.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s EBIT?
Personalis, Inc. (PSNL) reported EBIT of -$32.16M in Q1 2026.
How has Personalis, Inc.'s EBIT changed year-over-year?
Personalis, Inc.'s EBIT decreased by 81.7% year-over-year, from -$17.7M to -$32.16M.
What is the long-term trend for Personalis, Inc.'s EBIT?
Over 4 years (2021 to 2025), Personalis, Inc.'s EBIT has grown at a 7.7% compound annual growth rate (CAGR), from -$65.35M to -$88.06M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.